TrialInvestigational new drugs2012

Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors.

Thomas J Semrad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.